Ethical Criteria for Human Challenge Studies in Infectious Diseases

被引:81
作者
Bambery, Ben [1 ]
Selgelid, Michael [1 ]
Weijer, Charles [2 ]
Savulescu, Julian [3 ]
Pollard, Andrew J. [3 ]
机构
[1] Monash Univ, Clayton, Vic 3800, Australia
[2] Western Univ, Sydney, NSW, Australia
[3] Univ Oxford, Oxford OX1 2JD, England
基金
加拿大健康研究院;
关键词
RESEARCH PARTICIPATION; HUMAN VOLUNTEERS; MALARIA VACCINE; RESEARCH RISKS; PAYMENT; UPDATE; LIMITS; MODEL;
D O I
10.1093/phe/phv026
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Purposeful infection of healthy volunteers with a microbial pathogen seems at odds with acceptable ethical standards, but is an important contemporary research avenue used to study infectious diseases and their treatments. Generally termed 'controlled human infection studies', this research is particularly useful for fast tracking the development of candidate vaccines and may provide unique insight into disease pathogenesis otherwise unavailable. However, scarce bioethical literature is currently available to assist researchers and research ethics committees in negotiating the distinct issues raised by research involving purposefully infecting healthy volunteers. In this article, we present two separate challenge studies and highlight the ethical issues of human challenge studies as seen through a well-constructed framework. Beyond the same stringent ethical standards seen in other areas of medical research, we conclude that human challenge studies should also include: (i) independent expert reviews, including systematic reviews; (ii) a publicly available rationale for the research; (iii) implementation of measures to protect the public from spread of infection beyond the research setting; and (iv) a new system for compensation for harm. We hope these additions may encourage safer and more ethical research practice and help to safeguard public confidence in this vital research alternative in years to come.
引用
收藏
页码:92 / 103
页数:12
相关论文
共 35 条
[1]  
Academy of Medical Sciences, 2005, MICR CHALL STUD HUM
[2]   First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children [J].
Agnandji, Selidji Todagbe ;
Lell, Bertrand ;
Soulanoudjingar, Solange Solmeheim ;
Fernandes, Jose Francisco ;
Abossolo, Beatrice Peggy ;
Conzelmann, Cornelia ;
Methogo, Barbara Gaelle Nfono Ondo ;
Doucka, Yannick ;
Flamen, Arnaud ;
Mordmueller, Benjamin ;
Issifou, Saadou ;
Kremsner, Peter Gottfried ;
Sacarlal, Jahit ;
Aide, Pedro ;
Lanaspa, Miguel ;
Aponte, John J. ;
Nhamuave, Arlindo ;
Quelhas, Diana ;
Bassat, Quique ;
Mandjate, Sofia ;
Macete, Eusebio ;
Alonso, Pedro ;
Abdulla, Salim ;
Salim, Nahya ;
Juma, Omar ;
Shomari, Mwanajaa ;
Shubis, Kafuruki ;
Machera, Francisca ;
Hamad, Ali Said ;
Minja, Rose ;
Mpina, Maxmillian ;
Mtoro, Ali ;
Sykes, Alma ;
Ahmed, Saumu ;
Urassa, Alwisa Martin ;
Ali, Ali Mohammed ;
Mwangoka, Grace ;
Tanner, Marcel ;
Tinto, Halidou ;
D'Alessandro, Umberto ;
Sorgho, Hermann ;
Valea, Innocent ;
Tahita, Marc Christian ;
Kabore, William ;
Ouedraogo, Sayouba ;
Sandrine, Yara ;
Guiguemde, Robert Tinga ;
Ouedraogo, Jean Bosco ;
Hamel, Mary J. ;
Kariuki, Simon .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) :1863-1875
[3]  
[Anonymous], 2013, WMA DECLARATION HELS
[4]  
[Anonymous], 2013, MALARIA
[5]  
[Anonymous], ROUTLEDGE COMPANION
[6]  
Centers for Disease Control and Prevention, 2013, SMALLP DIS OV
[7]   Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge [J].
Church, LWP ;
Le, TP ;
Bryan, JP ;
Gordon, DM ;
Edelman, R ;
Fries, L ;
Davis, JR ;
Herrington, DA ;
Clyde, DF ;
Shmuklarsky, MJ ;
Schneider, I ;
McGovern, TW ;
Chulay, JD ;
Ballou, WR ;
Hoffman, SL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :915-920
[8]  
Cohen Baruch, 1990, J Halacha Contemporary Society, VNo. 19, P103
[9]  
Cohen MB, 1999, INFECT IMMUN, V67, P6346
[10]   The expanding vaccine development pipeline, 1995-2008 [J].
Davis, Matthew M. ;
Butchart, Amy T. ;
Coleman, Margaret S. ;
Singer, Dianne C. ;
Wheeler, John R. C. ;
Pok, Angela ;
Freed, Gary L. .
VACCINE, 2010, 28 (05) :1353-1356